CLL-115 First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Authors:
- Jennifer R. BrownJBJennifer R. Brown
- Peter HillmenPHPeter Hillmen
- Barbara EichhorstBEBarbara Eichhorst
- Nicole LamannaNLNicole Lamanna
- Susan O'BRienSOSusan O'BRien
- Constantine S. TamCTConstantine S. Tam
- Lugui QiuLQLugui Qiu
- Maciej KazmierczakMKMaciej Kazmierczak
- Keshu ZhouKZKeshu Zhou
- Martin ŠimkovičMŠMartin Šimkovič
- Jiri MayerJMJiri Mayer
- Amanda Gillespie-TwardyAGAmanda Gillespie-Twardy
- 20 September 2022
- journal article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22, S266